Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 26

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

231

HTML

1879

Figures (1-5)

187

Tables (1-2)

150

Sum=2447

Jul 14, 2011 (publication date) through May 17, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jul 14, 2011; 17(26): 3109-3116
Published online Jul 14, 2011. doi: 10.3748/wjg.v17.i26.3109

Table 2 Period between resection of primary tumor and resection of colorectal liver metastasis

¹Colorectal cancer patients with FOLFOX chemotherapy before colorectal cancer liver metastasis (CRLM) surgery;

²Colorectal cancer patients without FOLFOX chemotherapy before CRLM surgery.

Citation: Rubie C, Frick VO, Ghadjar P, Wagner M, Justinger C, Graeber S, Sperling J, Kollmar O, Schilling MK. Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases. World J Gastroenterol 2011; 17(26): 3109-3116
URL: https://www.wjgnet.com/1007-9327/full/v17/i26/3109.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i26.3109